PL362650A1 - Nowe sole inhibitorów CCK użyteczne terapeutycznie, sposób ich wytwarzania oraz zawierające je preparaty farmaceutyczne - Google Patents

Nowe sole inhibitorów CCK użyteczne terapeutycznie, sposób ich wytwarzania oraz zawierające je preparaty farmaceutyczne

Info

Publication number
PL362650A1
PL362650A1 PL01362650A PL36265001A PL362650A1 PL 362650 A1 PL362650 A1 PL 362650A1 PL 01362650 A PL01362650 A PL 01362650A PL 36265001 A PL36265001 A PL 36265001A PL 362650 A1 PL362650 A1 PL 362650A1
Authority
PL
Poland
Prior art keywords
preparation
pharmaceutical preparations
therapeutically useful
preparations containing
useful new
Prior art date
Application number
PL01362650A
Other languages
English (en)
Inventor
Istvan Hermecz
Agnes Horvath
Gyulane Kiss
Miklos Morvai
Benjamin Podanyi
Kalman Simon
Judit Sipos
Esek Agota Smelkone
Anna Szabo
Arpadne Vasvari
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of PL362650A1 publication Critical patent/PL362650A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL01362650A 2000-04-07 2001-04-04 Nowe sole inhibitorów CCK użyteczne terapeutycznie, sposób ich wytwarzania oraz zawierające je preparaty farmaceutyczne PL362650A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0001417A HUP0001417A2 (hu) 2000-04-07 2000-04-07 Gyógyászatilag alkalmazható új sók, eljárás előállításukra és azokat tartalmazó gyógyászati készítmények
PCT/HU2001/000039 WO2001077108A1 (en) 2000-04-07 2001-04-04 Therapeutically useful new salts of cck inhibitors, process for the preparation thereof and pharmaceutical preparations containing them

Publications (1)

Publication Number Publication Date
PL362650A1 true PL362650A1 (pl) 2004-11-02

Family

ID=89978239

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01362650A PL362650A1 (pl) 2000-04-07 2001-04-04 Nowe sole inhibitorów CCK użyteczne terapeutycznie, sposób ich wytwarzania oraz zawierające je preparaty farmaceutyczne

Country Status (21)

Country Link
US (1) US20030176475A1 (pl)
EP (1) EP1274707A1 (pl)
JP (1) JP2003530396A (pl)
KR (1) KR20020084296A (pl)
CN (1) CN1420885A (pl)
AU (1) AU2001248656A1 (pl)
BG (1) BG107219A (pl)
BR (1) BR0109890A (pl)
CA (1) CA2405004A1 (pl)
CZ (1) CZ20023671A3 (pl)
EA (1) EA200201076A1 (pl)
EE (1) EE200200582A (pl)
HU (2) HUP0001417A2 (pl)
IL (1) IL152005A0 (pl)
IS (1) IS6577A (pl)
MX (1) MXPA02009887A (pl)
NO (1) NO20024802L (pl)
PL (1) PL362650A1 (pl)
SK (1) SK15052002A3 (pl)
WO (1) WO2001077108A1 (pl)
ZA (1) ZA200207969B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY142390A (en) 2002-05-22 2010-11-30 Glaxosmithkline Llc 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
US7164383B2 (en) 2002-09-25 2007-01-16 The Board Of Regents Of The University Of Oklahoma Navigation system using locally augmented GPS
ECSP077628A (es) 2007-05-03 2008-12-30 Smithkline Beechman Corp Nueva composición farmacéutica
KR20120015355A (ko) 2009-05-29 2012-02-21 글락소스미스클라인 엘엘씨 트롬보포이에틴 효능제 화합물의 투여 방법
EP3453712B1 (en) * 2016-05-04 2022-08-17 Youngene Therapeutics Co., Ltd. Diethylamine solvate of sodium-glucose linked transporter inhibitor, and preparation method and application thereof
MX2022010548A (es) 2020-02-28 2022-09-23 Kallyope Inc Agonistas de gpr40.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4970713A1 (es) * 1997-09-19 2000-11-07 Sanofi Synthelabo Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
NO20024802D0 (no) 2002-10-04
KR20020084296A (ko) 2002-11-04
HUP0001417A2 (hu) 2002-12-28
US20030176475A1 (en) 2003-09-18
EE200200582A (et) 2004-04-15
CN1420885A (zh) 2003-05-28
EA200201076A1 (ru) 2003-04-24
BG107219A (bg) 2003-05-30
NO20024802L (no) 2002-10-04
BR0109890A (pt) 2003-06-03
IS6577A (is) 2002-10-02
JP2003530396A (ja) 2003-10-14
MXPA02009887A (es) 2003-06-17
SK15052002A3 (sk) 2003-05-02
EP1274707A1 (en) 2003-01-15
HUP0204476A2 (en) 2003-05-28
CZ20023671A3 (cs) 2003-05-14
AU2001248656A1 (en) 2001-10-23
WO2001077108A1 (en) 2001-10-18
ZA200207969B (en) 2004-02-10
HU0001417D0 (en) 2000-06-28
CA2405004A1 (en) 2001-10-18
IL152005A0 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
HUP0203122A3 (en) Fab i inhibitors, process for their preparation, pharmaceutical compositions containing them and their use
PL396568A1 (pl) Krystaliczny bursztynian O-demetylo-wenlafaksyny, kompozycja farmaceutyczna, farmaceutyczna postać dawkowania, doustna postać dawkowania, zastosowanie oraz sposób wytwarzania krystalicznego bursztynianu O-demetylo-wenlafaksyny
HUP0301325A3 (en) Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition
HUP0302474A3 (en) Therapeutically effective tropane derivatives, process for their preparation pharmaceutical compositions containing them and their use
HUP0203669A3 (en) Renin inhibitors, process for their preparation, pharmaceutical compositions containing them and their use
HUP0301344A3 (en) Non-steroidal inflammation inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0204519A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing them and process for their preparations
HUP0303891A3 (en) Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203548A3 (en) New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0101281A3 (en) Diphenyl-piperidine butanamides as glycine transport inhibitors, process for producing them, use of them for producing medicaments and the pharmaceutical compositions containing them
HUP0102723A3 (en) New diphenylurea derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0200881A2 (en) Renin inhibitors, process for preparation of the compounds, pharmaceutical compositions containing them and their use
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HUP0203597A3 (en) Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use
HUP0202233A3 (en) Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them
HUP0301075A3 (en) Diphenyl ether derivatives, their use for preparation of pharmaceutical compositions and process for preparation the compounds
HUP0302050A3 (en) Pharmaceutical form of administration for peptides, method for its production and use
HUP0204563A3 (en) Process for preparation of 3,3-diarylpropylamine derivatives and their intermediates and their use for preparation of pharmaceutical compositions
HUP0302099A3 (en) Azythromycin in the form of a monohydrate, process for its preparation and pharmaceutical composition containing in the monohydrate form
HUP0103712A3 (en) Salts of paroxetine, process for their preparation and their pharmaceutical use
IL152005A0 (en) Therapeutically useful new salts of cck inhibitors, process for the preparation thereof and and pharmaceutical preparations containing them
HUP0203212A3 (en) Integrin inhibitors, process for preparation thereof, their use preparation of pharmaceutical compositions and the compositions
HUP0203859A3 (en) Aminomethyl-phenyl-cyclohexanone derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0200376A3 (en) Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use
HUP0300066A3 (en) Polypeptide compounds, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)